Dopamine/glutamate interaction as studied by combining turning behaviour and c-Fos expression

Area of Science:

• Neuroscience
• Motor Control
• Basal Ganglia Function

Background:

• Dopamine (DA) and N-methyl-D-aspartate (NMDA) receptors are crucial for basal ganglia motor functions.
• Unilateral 6-hydroxydopamine (6-OHDA) lesions in rats create an imbalance in dopamine signaling, mimicking Parkinsonian motor deficits.
• The interaction between dopamine and NMDA receptors is complex and context-dependent, particularly in lesioned models.

Purpose of the Study:

• To investigate the differential effects of NMDA receptor blockade on dopamine D1 and D2 receptor-mediated motor behaviors in a rat model of Parkinson's disease.
• To explore how NMDA receptor antagonists modulate both acute turning responses and long-term sensitization induced by dopamine receptor stimulation.
• To correlate molecular changes (c-fos expression) with the observed behavioral effects of dopamine and NMDA receptor interactions.

Main Methods:

• Utilized unilaterally 6-hydroxydopamine (6-OHDA) lesioned rats to model basal ganglia dysfunction.
• Administered dopamine agonists and the NMDA antagonist MK 801 to assess turning behavior.
• Measured c-fos expression in the striatum to evaluate neuronal activity related to receptor stimulation and blockade.

Main Results:

• NMDA receptor blockade differentially modulated turning behavior: potentiated D1 agonist-induced turning and decreased D2 agonist-induced turning.
• MK 801 prevented the sensitization (priming) of D1-mediated turning behavior after a single dopamine agonist exposure.
• Fos-like immunoreactivity correlated with long-term effects of dopamine receptor stimulation and NMDA receptor blockade, not acute effects.

Conclusions:

• NMDA receptor activity critically influences the balance of dopamine D1 and D2 receptor signaling in motor control within the basal ganglia.
• NMDA receptor blockade has distinct effects on acute motor responses versus the development of motor sensitization.
• The findings highlight the complex interplay between glutamatergic and dopaminergic systems in motor adaptation and potential therapeutic targets.